Statistics for A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer

Total visits

views
A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer 247

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
Heinemann_2016_A-study.pdf 272
java.util.UUID:38e18728-68c2-4e78-8498-e6424f6b1e63 40
java.util.UUID:01de6884-661e-4ad9-b818-989f68981341 6
java.util.UUID:74854f8e-103f-402e-9f41-c79629621913 6

Top country views

views
United States 150
Germany 17
Ukraine 9
China 8
Russia 4
Sweden 4
Australia 3
Canada 3
United Kingdom 2
Italy 2
Spain 1
Greece 1
Ireland 1
Israel 1
Malaysia 1
Taiwan 1

Top city views

views
Wilmington 47
Fairfield 17
Kiez 13
Ann Arbor 11
Kiev 9
Cambridge 8
Houston 8
Jacksonville 7
Beijing 3
Chicago 3
Rockville 3
Saint Petersburg 3
Stockholm 3
Tokyo 3
Washington 3
Duncan 2
Grùmolo 2
Guangzhou 2
Lake Mary 2
San Francisco 2
Toronto 2
White Plains 2
Abingdon 1
Borås 1
Brooklyn 1
Canberra 1
Chongqing 1
Clayton 1
Dublin 1
Gunzenhausen 1
Hamilton 1
Irvine 1
Kaohsiung 1
Kwinana 1
Leipzig 1
Moscow 1
Mountain View 1
Norwalk 1
Philadelphia 1
Piraeus 1
San Sebastian 1
Scottsdale 1
Seremban 1
Setagaya 1
Shenzhen 1
Tel Aviv 1
Ube 1
Wuppertal 1